This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bai, R. Articles by Hamel, E. Search for Related Content PubMed PubMed Citation Articles by Bai, R. Articles by Hamel, E.

Characterization of the Interaction of Cryptophycin 1 with Tubulin: Binding in the Vinca Domain, Competitive Inhibition of Dolastatin 10 Binding, and an Unusual Aggregation Reaction

Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, NIH, Bethesda, Maryland 20892 [R. B., E. H.]; Merck, Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065 [R. E. S.]; Research Triangle Institute, Research Triangle Park, North Carolina 27709 [J. A. K.]; and Cancer Research Institute and Department of Chemistry, Arizona State University, Tempe, Arizona 85287 [G. R. P.]

The antimitotic depsipeptide cryptophycin 1 (CP1) was compared to the antimitotic peptide dolastatin 10 (D10) as an antiproliferative agent and in its interactions with purified tubulin. The potent activity of CP1 as an inhibitor of cell growth was confirmed. The agent had an IC₅₀ of 20 pM against L1210 murine leukemia cells versus 0.5 nM for D10. Both drugs were comparable as inhibitors of the glutamate-induced assembly of purified tubulin, with D10 being slightly more potent. CP1, like D10, was a noncompetitive inhibitor of the binding of [³H]vinblastine to tubulin (apparent K_i, 3.9 µM); and the depsipeptide was a competitive inhibitor of the binding of [³H]D10 to tubulin (apparent K_i, 2.1 µM). CP1 was less potent than D10 as an inhibitor of nucleotide exchange on tubulin, but the two drugs were equivalent in stabilizing the colchicine binding activity of tubulin. CP1, like D10, caused the formation of extensive structured aggregates of tubulin when present in stoichiometric amounts relative to the protein. Whereas at lower concentrations the drugs were equivalent in causing formation of small oligomers detected by gel permeation high-performance liquid chromatography, there were notable differences in the aggregation reactions induced by the two drugs. The electron micro-graphic appearance of the D10-induced aggregate differed substantially from that of the CP1-induced aggregate. With D10, but not CP1, aggregate morphology was greatly altered in the presence of microtubule-associated proteins. Finally, although CP1 caused the formation of massive aggregates, as did D10, there was little turbidity change with the depsipeptide as opposed to the peptide.

¹ To whom requests for reprints should be addressed, at Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, NIH, Building 37, Room 5C25, Bethesda, MD 20892. Phone: (301) 496-4855; Fax: (301) 496-5839.

Received 4/ 8/96. Accepted 7/30/96.

This article has been cited by other articles:

				D. A. Dabydeen, J. C. Burnett, R. Bai, P. Verdier-Pinard, S. J. H. Hickford, G. R. Pettit, J. W. Blunt, M. H. G. Munro, R. Gussio, and E. Hamel Comparison of the Activities of the Truncated Halichondrin B Analog NSC 707389 (E7389) with Those of the Parent Compound and a Proposed Binding Site on Tubulin Mol. Pharmacol., December 1, 2006; 70(6): 1866 - 1875. [Abstract] [Full Text] [PDF]

				J. M. Mulligan, L. M. Greene, S. Cloonan, M. M. Mc Gee, V. Onnis, G. Campiani, C. Fattorusso, M. Lawler, D. C. Williams, and D. M. Zisterer Identification of Tubulin as the Molecular Target of Proapoptotic Pyrrolo-1,5-benzoxazepines Mol. Pharmacol., July 1, 2006; 70(1): 60 - 70. [Abstract] [Full Text] [PDF]

				R. Bai, D. G. Covell, G. F. Taylor, J. A. Kepler, T. D. Copeland, N. Y. Nguyen, G. R. Pettit, and E. Hamel Direct Photoaffinity Labeling by Dolastatin 10 of the Amino-terminal Peptide of {beta}-Tubulin Containing Cysteine 12 J. Biol. Chem., July 16, 2004; 279(29): 30731 - 30740. [Abstract] [Full Text] [PDF]

				Z. Cruz-Monserrate, H. C. Vervoort, R. Bai, D. J. Newman, S. B. Howell, G. Los, J. T. Mullaney, M. D. Williams, G. R. Pettit, W. Fenical, et al. Diazonamide A and a Synthetic Structural Analog: Disruptive Effects on Mitosis and Cellular Microtubules and Analysis of Their Interactions with Tubulin Mol. Pharmacol., June 1, 2003; 63(6): 1273 - 1280. [Abstract] [Full Text] [PDF]

				R. Bai, P. Verdier-Pinard, S. Gangwar, C. C. Stessman, K. J. McClure, E. A. Sausville, G. R. Pettit, R. B. Bates, and E. Hamel Dolastatin 11, a Marine Depsipeptide, Arrests Cells at Cytokinesis and Induces Hyperpolymerization of Purified Actin Mol. Pharmacol., March 1, 2001; 59(3): 462 - 469. [Abstract] [Full Text]

				N. R. Watts, D. L. Sackett, R. D. Ward, M. W. Miller, P. T. Wingfield, S. S. Stahl, and A. C. Steven HIV-1 Rev Depolymerizes Microtubules to Form Stable Bilayered Rings J. Cell Biol., July 24, 2000; 150(2): 349 - 360. [Abstract] [Full Text] [PDF]

				P. Verdier-Pinard, J. A. Kepler, G. R. Pettit, and E. Hamel Sustained Intracellular Retention of Dolastatin 10 Causes Its Potent Antimitotic Activity Mol. Pharmacol., January 1, 2000; 57(1): 180 - 187. [Abstract] [Full Text]

				D. Panda, K. DeLuca, D. Williams, M. A. Jordan, and L. Wilson Antiproliferative mechanism of action of cryptophycin-52: Kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends PNAS, August 4, 1998; 95(16): 9313 - 9318. [Abstract] [Full Text] [PDF]